HIF1A and osteoporosis: The acyclic isoprenoid compound GGA, a known inducer of HSP70 expression through activation of HSF1, has been used in clinical antiulcer therapy.50 After in vivo GGA treatment, we observed suppression of HIF-1α signaling, a decrease in RANKL production and protection against osteoporosis.